chr9-132927248-G-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000368.5(TSC1):c.163C>T(p.Gln55*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000368.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - tuberous sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
 - lung lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TSC1 | ENST00000298552.9  | c.163C>T | p.Gln55* | stop_gained | Exon 4 of 23 | 1 | NM_000368.5 | ENSP00000298552.3 | ||
| TSC1 | ENST00000490179.4  | c.163C>T | p.Gln55* | stop_gained | Exon 5 of 24 | 3 | ENSP00000495533.2 | 
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD4 exome Cov.: 31 
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
Tuberous sclerosis 1    Pathogenic:2 
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 48808). This variant has not been reported in the literature in individuals affected with TSC1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln55*) in the TSC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC1 are known to be pathogenic (PMID: 10227394, 17304050). -
This variant creates a premature translational stop signal. It is expected to result in a protein truncation or nonsense mediated decay. Several tools classified the variant as pathogenic: BayesDel addAF, BayesDel noAF, EIGEN, FATHMM-XF, MutationTaster. ACMG criteria: PVS1 (LOF), PP4 (phenotype match), PM2 (absent from controls), PP3 (in silico evidence), PS2 (de novo)= Pathogenic. Based on the evidence outlined above, the variant was classified as Pathogenic. -
not provided    Pathogenic:1 
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 21309039) -
Tuberous sclerosis syndrome    Other:1 
- -
Malignant tumor of urinary bladder    Other:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at